Literature DB >> 28544294

Factors affecting the timeliness and adequacy of haematuria assessment in bladder cancer: a systematic review.

Brian Ngo1,2, Marlon Perera1,2, Nathan Papa1,2, Damien Bolton1,2, Shomik Sengupta1,2.   

Abstract

OBJECTIVES: To review the literature to identify factors affecting haematuria assessment in bladder cancer.
METHODS: We performed a systematic review in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Publications indexed in EMBASE and Medline (PubMed) in March 2016 were searched, using the keywords 'hematuria', 'urinary bladder neoplasm(s)' and 'bladder tumor'. Studies evaluating the timeliness and adequacy of haematuria assessment in the context of bladder cancer were included. Exclusion criteria included age <18 years, animal studies and non-English articles.
RESULTS: Following our search strategy, a total of 17 articles were included in our study. All 17 studies commented on gender, with female gender associated with delayed and inadequate haematuria evaluation. Women waited longer than men for urological review (three studies) and bladder cancer diagnosis (three studies). Women were also less likely to be referred to urology (two studies), receive imaging (three studies) or have cystoscopy (two studies). In all, 10 studies commented on age, with the impression that advancing age is associated with a more thorough assessment. Smokers and those with microscopic haematuria appear to undergo a less thorough evaluation.
CONCLUSION: Female gender is associated with sub-optimal haematuria evaluation, while older patients are evaluated more thoroughly. Smokers paradoxically undergo less comprehensive assessment. Further research on the impact of other factors is required.
© 2017 The Authors BJU International © 2017 BJU International Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  bladder cancer; diagnosis; haematuria; timeliness; urinary bladder neoplasm

Mesh:

Year:  2017        PMID: 28544294     DOI: 10.1111/bju.13821

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  5 in total

Review 1.  Image-Guided Transurethral Resection of Bladder Tumors - Current Practice and Future Outlooks.

Authors:  Timothy C Chang; Gautier Marcq; Bernhard Kiss; Dharati R Trivedi; Kathleen E Mach; Joseph C Liao
Journal:  Bladder Cancer       Date:  2017-07-27

2.  Diagnostic accuracy of NMP 22 and urine cytology for detection of transitional cell carcinoma urinary bladder taking cystoscopy as gold standard.

Authors:  Muhammad Tanveer Sajid; Muhammad Rafiq Zafar; Hussain Ahmad; Saif Ullah; Zahoor Iqbal Mirza; Khubaib Shahzad
Journal:  Pak J Med Sci       Date:  2020 May-Jun       Impact factor: 1.088

Review 3.  A systematic review and meta-analysis on delaying surgery for urothelial carcinoma of bladder and upper tract urothelial carcinoma: Implications for the COVID19 pandemic and beyond.

Authors:  Jeffrey J Leow; Wei Shen Tan; Wei Phin Tan; Teck Wei Tan; Vinson Wai-Shun Chan; Kari A O Tikkinen; Ashish Kamat; Shomik Sengupta; Maxwell V Meng; Shahrokh Shariat; Morgan Roupret; Karel Decaestecker; Nikhil Vasdev; Yew Lam Chong; Dmitry Enikeev; Gianluca Giannarini; Vincenzo Ficarra; Jeremy Yuen-Chun Teoh
Journal:  Front Surg       Date:  2022-10-04

4.  Quality of the diagnostic process in patients presenting with symptoms suggestive of bladder or kidney cancer: a systematic review.

Authors:  Yin Zhou; Marije van Melle; Hardeep Singh; Willie Hamilton; Georgios Lyratzopoulos; Fiona M Walter
Journal:  BMJ Open       Date:  2019-10-03       Impact factor: 2.692

Review 5.  The Role of Estrogen Receptors in Urothelial Cancer.

Authors:  Takuro Goto; Hiroshi Miyamoto
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-16       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.